Patent · US Active

Use of antibodies for the vaccination against cancer

US8444974B2 · kind B2 · utility

0Cited by
5References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2011
Grant dateMay 21, 2013
Priority date—
Expiry dateAug 12, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55566
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described is the use of antibodies which are directed against human cellular membrane antigens for the vaccination against cancer diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.